The impact of the COVID-19 pandemic has been felt globally. At the Pfizer Clinical Research Unit (PCRU), the safety of participants and staff has always been our top priority. We’ve updated our facility and procedures to meet the recommended guidance related to the pandemic, including socially distanced spaces, routine testing, increased cleaning and sanitization, and limiting our on-site capacity.
As a result of these updates — and the trust of those who continue to participate — we have been able to successfully run clinical trials in this unprecedented time. Together, we can keep making a difference for patients around the world while ensuring a safe, clean environment.
COVID-19 safety at the PCRU
Masks are required throughout the facility and will be provided to participants
COVID-19 tests and symptom checks are routinely administered throughout study participation
All shared spaces, including exam rooms, are disinfected between each use
Social distancing is enforced, and occupancy is limited for all rooms
On-site staffing has been reduced and our appointment schedule is now staggered to reduce interaction
Both staff and participants receive daily temperature checks
Hand sanitizer stations have been installed throughout the facility